Intellectual Property
We have an aggressive IP strategy that includes a patent on non-invasive, comprehensive, hormone testing and provisional filings on our technology and genetic integrations, as well as trademarks as applicable.
We are ending the spread of misinformation one healthcare specialty at a time.
Our first release was FertilityAnswers which now has:
- 50% of US infertility clinics enaged
- 3000 new registered users a month
- Aggressive IP portfolio
- Revenue stage: growth
- 2M data points collected on users
- 89% of users opt-in for a fertility consult
The Covid-19 “infodemic”, a term coined by the World Health Organization (WHO) to describe the dangerous nature of misinformation in the face of a health crisis, underscores the utility of applying our technology assets to any specialty area of healthcare. Access to correct, unbiased, personalized health care information can be the difference between suffering and healing, affordable treatment or snake oil, and even can mean the difference between life and death. MedAnswers is seeking partners to rapidly expand into other health are verticals, a few of which are described below.
More than 30% of the US population is peri-menopausal or menopausal. Their average time with their OBGYN is 7 minutes per year. They need efficient access to accurate information.
Market dominant patient engagement platform connecting REIs to fertility patients who need them to conceive.
One billion people in the world suffer from Migraines. Having access to reliable pharmacological and non-pharmacological information could prevent years of unnecessary suffering.
One billion people in the world suffer from Obesity . Having access to reliable pharmacological and non-pharmacological information could prevent years of unnecessary suffering.
Given the increasing number of obesity cases, the cost of diabetes rose 26% in the last five years. Rapid interventions to prevent the development of type 2 diabetes would save the US health system significantly.
Accessing 2nd and 3rd opinions when diagnosed with cancer, as well as more easily accessing clinical trials could be the difference between life and death.
Female led and majority owned, fully remote team with 6 exits & 6 aquisitions.
We have an aggressive IP strategy that includes a patent on non-invasive, comprehensive, hormone testing and provisional filings on our technology and genetic integrations, as well as trademarks as applicable.
Our first vertical, FertilityAnswers, was started by fertility patients, advocates, researchers and physicians who serve the market. We've worked alongside advocacy organizations and non-profits to increase access to care, better serve patients and democratize pricing. Volunteerism is a core part of every disease state in which humans are suffering. We strongly encourage our employees and partners to lend their voice to worthy causes, to make a difference in their daily actions and open their hearts to giving back.